Rapid Assessment of Illicit Drugs in Wastewater

Information

  • Research Project
  • 9991451
  • ApplicationId
    9991451
  • Core Project Number
    R43DA051105
  • Full Project Number
    1R43DA051105-01
  • Serial Number
    051105
  • FOA Number
    RFA-DA-20-021
  • Sub Project Id
  • Project Start Date
    4/1/2020 - 4 years ago
  • Project End Date
    9/30/2020 - 3 years ago
  • Program Officer Name
    ANGELONE, LEONARDO MARIA
  • Budget Start Date
    4/1/2020 - 4 years ago
  • Budget End Date
    9/30/2020 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    01
  • Suffix
  • Award Notice Date
    3/11/2020 - 4 years ago
Organizations

Rapid Assessment of Illicit Drugs in Wastewater

PROJECT SUMMARY/ABSTRACT Opioid misuse and abuse is an epidemic of global concern to public health and safety, causing over 60,000 deaths annually in the United States. Obtaining real-time data on the misuse/abuse of opioids is a major challenge as this information is limited to population surveys and drug surveillance data. There is an urgency to develop smart city tools that will measure and monitor illicit drug metabolites to achieve crucial insight into the prevalence of opioid misuse/abuse without stigmatizing communities. Monitoring opioid metabolites in wastewater is a proven strategy to identify areas needing intervention instead of relying on emergency-room statistics and overdose deaths. However, current wastewater drug analysis requires costly laboratory-based tests that involves labor intensive sample collection, transportation, and analysis, resulting in long (days) turnaround times. Giner proposes to develop a compact, label-free Graphene Field Effect Transistor (G-FET) sensor utilizing high-specificity aptamers for rapid, accurate, and cost-effective monitoring of illicit drugs and their metabolites in wastewater samples. Since it generates rapid results compared to incumbent methods which rely on batch sampling of wastewater streams, and expensive, time consuming analysis, this technology will provide actionable real time data at a fraction of the cost of incumbent methods, encouraging broad use. The goal of Phase I program is to demonstrate a proof-of-concept test for two major street heroine metabolites in wastewater at pg/mL levels: Morphine and Norfentanyl. Multiple samples from wastewater treatment plants will be analyzed with Giner?s assay and results will be cross-validated using the gold standard HPLC-MS/MS method. The Specific Aims of the Phase I effort incide: 1) Development of a wastewater G-FET assay for Morphine and Norfentanyl; 2) Validation of sensor sensitivity and specificity; and 3) Sensor performance testing in real wastewater samples. Once developed, the technology will also be suitable for detection of any target illicit drug for which an aptamer can be prepared.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R43
  • Administering IC
    DA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    252131
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
  • Funding ICs
    NIDA:252131\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZDA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GINER, INC.
  • Organization Department
  • Organization DUNS
    066594979
  • Organization City
    NEWTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    024661311
  • Organization District
    UNITED STATES